29 . February , 2020 - Saturday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Methylprednisolone

Big Image Pronouncation: (METH-ill-pred-NIH-suh-lone)
Class: Glucocorticoid

Trade Names:
- Tablets 2 mg
- Tablets 4 mg
- Tablets 8 mg
- Tablets 16 mg
- Tablets 24 mg
- Tablets 32 mg

Depo-Medrol (Canada)
Methylprednisolone Sodium Succinate

Trade Names:
- Powder for injection 125 mg per vial
- Powder for injection 500 mg per vial
- Powder for injection 1 g per vial

Trade Names:
- Powder for injection 125 mg per vial
- Powder for injection 500 mg per vial
- Powder for injection 1 g per vial
- Powder for injection 2 g per vial

Methylprednisolone Acetate

Trade Names:
depMedalone 40
- Injection 40 mg/mL suspension

Trade Names:
depMedalone 80
- Injection 80 mg/mL suspension

Trade Names:
- Injection 20 mg/mL suspension
- Injection 40 mg/mL suspension
- Injection 80 mg/mL suspension

Trade Names:
- Injection 40 mg/mL suspension

Trade Names:
- Injection 80 mg/mL suspension

Trade Names:
Medralone 40
- Injection 40 mg/mL suspension

Trade Names:
Medralone 80
- Injection 80 mg/mL suspension

Mechanism of Action


Depresses formation, release and activity of endogenous mediators of inflammation including prostaglandins, kinins, histamine, liposomal enzymes and complement system. Modifies body's immune response.



Plasma t 1/ 2 is longer than 3.5 hr.


Onset is 6 to 48 hr (IM).


Times to peak effect are 4 to 8 days (IM) and 1 to 2 hr (oral).


Durations are 1.25 to 1.5 days (oral) and 1 to 4 wk (IM).

Indications and Usage

Replacement therapy in primary or secondary adrenal cortex insufficiency; adjunctive therapy for short-term administration in rheumatic disorders; exacerbation or maintenance therapy in collagen diseases; treatment of dermatologic diseases; control of allergic states or allergic and inflammatory ophthalmic processes; management of respiratory diseases; treatment of hematologic disorders; palliative management of neo-plastic diseases; management of cerebral edema associated with primary or metastatic brain tumor, craniotomy or head injury; induction of diuresis in edematous states (from nephrotic syndrome); management of critical exacerbations of GI diseases; management of acute exacerbations of multiple sclerosis; treatment of tuberculous meningitis; management of trichinosis with neurologic or myocardial involvement.

Intra-articular or soft tissue administration

Adjunctive therapy for short-term administration in synovitis of osteoarthritis, rheumatoid arthritis, bursitis, acute gouty arthritis, epicondylitis, acute nonspecific tenosynovitis and posttraumatic osteoarthritis.

Intralesional administration

Management of keloids; treatment of localized hypertrophic, infiltrated, inflammatory lesions of lichen planus, psoriatic plaques, granuloma annulare, lichen simplex chronicus; treatment of discoid lupus erythematosus, necrobiosis lipoidica diabeticorum, alopecia areata and cystic tumors of aponeurosis or tendon.

Unlabeled Uses

Reduction of mortality in severe alcoholic hepatitis; prevention of respiratory distress syndrome; treatment of septic shock; improvement of neurologic function in acute spinal cord injury.


Systemic fungal infections; idiopathic thrombocytopenic purpura (IM administration); administration of live virus vaccines; topical monotherapy in primary bacterial infections; topical use on face, groin or axilla; use in premature infants (sodium succinate salt).

Dosage and Administration


PO 4 to 48 mg/day.

Methylprednisolone Sodium Succinate

IV/IM 10 to 40 mg administered over 1 to several min. In severe condition, 30 mg/kg infused over 30 min; may repeat q 4 to 6 hr for 48 to 72 hr.

Infants and Children

IV/IM Not less than 0.5 mg/kg/24 hr.

Methylprednisolone Acetate

IM 40 to 120 mg q wk for 1 to 4 wk. Intra-articular/intralesional 4 to 80 mg into joints or lesions.

General Advice

  • Administer once-daily dose or alternate-day dosing in morning before 9 am.
  • With intra-articular injection, inject into synovial space. Do not inject unstable joints.
  • When treating conditions such as tendonitis or tenosynovitis, inject into tendon sheath rather than into substance of tendon.
  • When treating conditions such as epicondylitis, outline area of greatest tenderness and infiltrate drug into area.
  • When treating ganglia of tendon sheaths, inject drug directly into cyst.
  • When treating dermatologic conditions, avoid injection of sufficient material to cause blanching, which may cause small slough.
  • Do not inject into deltoid muscle. Administer IM injection deeply into gluteal muscle.
  • Although methylprednisolone sodium succinate can be given both IM and IV, methylprednisolone acetate can only be administered IM; it cannot be administered IV.
  • Do not use topically on face, groin, or axilla.


Store at room temperature (59° to 86°F).

Drug Interactions


May antagonize anticholinesterase effects in myasthenia gravis.


May decrease pharmacologic effect of methylprednisolone.

Hydantoins, rifampin

May increase clearance and decrease efficacy of methylprednisolone.


May decrease clearance of methylprednisolone.

Macrolide antibiotics

Significantly decreases methylprednisolone clearance; may need to decrease dose.


May reduce serum levels and efficacy of salicylates.

Laboratory Test Interactions

Drug may cause increased levels of urine glucose and serum cholesterol, decreased serum levels of potassium, T 3 and T 4 , decreased uptake of thyroid I 131 , false-negative result in nitroblue-tetrazolium test for systemic bacterial infection and suppression of skin-test reactions.

Adverse Reactions


Thromboembolism or fat embolism; thrombophlebitis; necrotizing angiitis; cardiac arrhythmias or ECG changes; syncopal episodes; hypertension; myocardial rupture; fatal arrest; circulatory collapse; CHF.


Convulsions; pseudotumor cerebri (increased intracranial pressure with papilledema); vertigo; headache; neuritis; paresthesias; psychosis.


Impaired wound healing; thin, fragile skin; petechiae and ecchymoses; erythema; lupus erythematosus-like lesions; subcutaneous fat atrophy; striae; hirsutism; acneiform eruptions; allergic dermatitis; urticaria; angioneurotic edema; perineal irritation; hyperpigmentation or hypopigmentation; burning, itching, irritation, dryness, folliculitis, hypertrichosis, pruritus, perioral dermatitis, allergic contact dermatitis, stinging, cracking and tightening of skin, secondary infections, skin atrophy, miliaria, telangiectasia (topical).


Posterior subcapsular cataracts; increased intraocular pressure; glaucoma; exophthalmos.


Pancreatitis; abdominal distention; ulcerative esophagitis; nausea; vomiting; increased appetite and weight gain; peptic ulcer with perforation and hemorrhage; bowel perforation.


Increased or decreased motility and number of spermatozoa.




Sodium and fluid retention; hypokalemia; hypokalemic alkalosis; metabolic alkalosis; hypocalcemia.


Musculoskeletal effects (eg, weakness, myopathy, muscle mass loss, osteoporosis, spontaneous fractures); endocrine abnormalities (eg, menstrual irregularities, cushingoid state, growth suppression in children, sweating, decreased carbohydrate tolerance, hyperglycemia, glycosuria, increased insulin or sulfonylurea requirements in diabetic patients, hirsutism); anaphylactoid or hypersensitivity reactions; aggravation or masking of infections; fatigue; insomnia; osteonecrosis, tendon rupture, infection, skin atrophy, postinjection flare, hypersensitivity, facial flushing (intra-articular administration). Topical application may produce adverse reactions seen with systemic use because of absorption.



Pregnancy category undetermined (systemic use); Category C (topical use).


Excreted in breast milk.


May be more susceptible to adverse effects from topical use. Benzyl alcohol/gasping syndrome may occur with use of methylprednisolone sodium succinate.


May require lower doses.


Reactions, including anaphylaxis, may occur rarely.

Tartrazine Sensitivity

May contain tartrazine, which may cause allergic-type reactions in susceptible individuals.

Adrenal suppression

Prolonged therapy may lead to hypothalamic-pituitary-adrenal suppression.


Drug may be harmful in chronic active hepatitis positive for hepatitis B surface antigen.


Because drug causes immunosuppressed state, do not administer live virus vaccines during treatment.


May mask signs of infection. May decrease host-defense mechanisms to prevent dissemination of infection.

Ocular effects

Use drug systemically with caution in ocular herpes simplex because of risk of possible corneal perforation.

Peptic ulcer

Drug may contribute to peptic ulceration, especially in large doses.

Repository injections

Do not inject subcutaneously. Avoid injection into deltoid muscle and repeated intramuscular injection into same site.


Increased dosage of rapidly acting corticosteroid may be needed before, during and after stressful situations.



Cushingoid changes, moonface, central obesity, striae, hirsutism, acne, ecchymoses, hypertension, osteoporosis, myopathy, sexual dysfunction, diabetes mellitus, hyperlipidemia, peptic ulcer, increased susceptibility to infection, electrolyte and fluid imbalance.

Patient Information

  • Instruct patient to take medication at same time each day and with food if taking orally.
  • With cream or ointment application, instruct patient to soak area of skin before gently applying light film of medication, to increase absorption. Caution patient to wash hands before and after application.
  • Encourage patient to eat low-sodium, low-fat foods.
  • Advise patient to practice frequent, thorough handwashing to help to prevent infections.
  • Advise patient on chronic steroid therapy to wear or carry identification (eg, Medi-Alert ) indicating condition and medication regimen.
  • Inform patient of potential for mood swings.
  • Warn patient regarding increasing appetite and consequent weight gain. Instruct patient to weigh self daily.
  • Inform patient of moonface, which often occurs with this medication.
  • Advise patient of acne and skin flushing, which are often associated with this medication. Instruct patient in proper skin care practices to help to prevent irritation and/or acne.
  • Instruct patient to report the following symptoms to health care provider: swelling in feet and ankles, signs of infection (eg, fever, over-growth in mouth, vaginal yeast, wound not healing or with drainage), diarrhea, nausea, vomiting, weight loss, discolored or painful urine, vision changes, menstrual irregularity and fatigue.

Recent Drug Updates at DrugIndexOnline:

anti-inhibitor coagulant complex injectable anti-inhibitor coagulant complex injectable
Generic Name: anti-inhibitor coagulant complex (injectable) (an TEE in HIH bih tor coe AG you lant COM plex) Brand Names: Autoplex T, Feiba VH What is anti-inhibitor coagulant complex? Anti-inhibitor coagulant complex is made up of proteins normally present in the blood that allow the bl more...

Coricidin HBP Congestion/Cough Coricidin HBP Congestion/Cough
Generic Name: Dextromethorphan/Guaifenesin Capsules and Tablets (DEX-troe-meth-OR-fan/gwye-FEN-e-sin) Brand Name: Examples include Coricidin HBP Congestion/Cough and Humibid CSCoricidin HBP Congestion/Cough is used for:Temporarily relieving cough due to the common cold, upper respiratory tract more...

Etonogestrel Etonogestrel
Pronouncation: (e-toe-noe-JES-trel) Class: Contraceptive hormone Trade Names: Implanon - Implant 68 mg Mechanism of Action Pharmacology Suppresses ovulation, increases viscosity of the cervical mucus, and alters the endometrium. Pharmacokinetics Absorption Bioavailability is approximately 100%. Mea more...

Some commonly used brand names are: In the U.S.— Calciparine HEP-LOCK U/P Liquaemin In Canada— Calcilean Calciparine Hepalean Heparin Leo Generic name product may be available in the U.S. and Canada. Category Anticoagulant Description Heparin (HEP-a-rin) is an anticoagula more...

Matulane Matulane
Generic Name: procarbazine (pro CAR bah zeen) Brand Names: Matulane What is Matulane (procarbazine)? Procarbazine is a cancer (antineoplastic) medication. Procarbazine interferes with the growth of cancer cells and slows their growth and spread in the body. Procarbazine is used to treat more...

Mevacor Mevacor
Some commonly used brand names are: In the U.S.— Altoprev 4 Lescol 3 Lipitor 1 Mevacor 4 Pravachol 5 Zocor 6 Note: Baycol was removed from the U.S. market by Bayer in August 2001. In Canada— Lescol 3 Mevacor 4 Pravachol 5 Zocor 6 Other commonly used names are: Epistati more...

Mobic Mobic
Generic Name: meloxicam (mel OKS i kam) Brand Names: Mobic What is meloxicam? Meloxicam is in a group of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). Meloxicam works by reducing hormones that cause inflammation and pain in the body. Meloxicam is used to treat pain or infla more...

Pediazole Pediazole
Generic name: Erythromycin ethylsuccinate, Sulfisoxazole acetyl Brand names: Eryzole, Pediazole Why is Pediazole prescribed? Pediazole is prescribed for the treatment of severe middle ear infections in children. Most important fact about Pediazole Sulfisoxazole is one of a group of drugs calle more...